Research Article
Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?
Table 2
Distribution of the studied cases according to different parameters in all studied groups.
| Parameter | No. (%) |
| Group 1 (n = 57) |
| Age (years) | | Mean ± SD | 49.3 ± 13.6 | Median (min–max.) | 43 (28–72) | Menopausal status | | Premenopausal | 32 (56.1%) | Postmenopausal | 25 (43.9%) | Oral contraceptive history | | Negative | 29 (50.9%) | Positive | 28 (49.1%) | Atypia | | No atypia | 32 (56.1%) | Atypia | 25 (43.9%) | BMI (kg/m2) | | Nonobese (<30) | 34 (59.6%) | Obese (≥30) | 23 (40.4%) | Mean ± SD | 30.5 ± 7.4 | Median (min–max.) | 28 (18–45) | Estradiol level | | ≤300 | 37 (64.9%) | >300 | 20 (35.1%) | Mean ± SD | 247.8 ± 124.6 | Median (min–max.) | 240 (60–450) |
| Group 2 (n = 57) |
| Histologic type | | Disordered proliferative endometrium | 22 (38.6%) | Atrophic endometrium | 5 (8.8%) | Senile cystic fibrosis | 6 (10.5%) | Benign endometrial hyperplasia | 24 (42.1%) |
| Group 3 (n = 68) |
| Histologic type | | Serous | 16 (23.5%) | Conventional | 52 (76.5%) |
|
|